maXXzen Platinum 12000 Capsule Recalled for Undisclosed Drug Contaminants
The FDA is recalling maXXzen Platinum 12000 capsules distributed nationwide because the product was marketed without an approved application and contains undisclosed pharmaceutical ingredients (Sildenafil and Tadalafil).
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class I recall for an unapproved drug product containing undisclosed pharmaceutical agents (Sildenafil and Tadalafil). Class I recalls meet the threshold for Severe (score 4) per the rubric, as they represent serious public health hazards.
Plain-English summary
The U.S. Food and Drug Administration (FDA) is recalling maXXzen Platinum 12000 capsule, 1-count blister card (UPC 7 18122 04072 8), manufactured by Miracle 8989 and distributed by Maxx Inc, Los Angeles, CA 90028.
The product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). Upon inspection, the product was found to be tainted with Sildenafil and Tadalafil, active pharmaceutical ingredients not declared on the product labeling.
This product was distributed nationwide in the United States. All lots remaining within expiration date are subject to this recall.
Consumers who have purchased this product should stop use immediately. Those with questions about this recall should contact the FDA or the recalling firm.
The recalled product
- Product
- maXXzen Platinum 12000 capsule, 1-count blister card (UPC 7 18122 04072 8), Distributed by: Maxx Inc, Los Angeles, CA 90028
- Manufacturer
- Miracle 8989
- Hazard
- unapproved-drug
- undisclosed-sildenafil
- undisclosed-tadalafil
- mislabeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots remaining within expiry.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27